BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 25744048)

  • 1. Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma.
    Xia Q; Dong S; Bian PD; Wang J; Li CJ
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1037-43. PubMed ID: 25744048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of thyroid hormone supplementation after thyroid lobectomy.
    Lee DY; Seok J; Jeong WJ; Ahn SH
    J Surg Res; 2015 Jan; 193(1):273-8. PubMed ID: 25088372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levothyroxine Cessation After Thyroid Lobectomy for Papillary Thyroid Cancer Can Be Achieved at the Same Rate as that for Benign Tumors Regardless of the Duration of Thyroid-stimulating Hormone Suppression.
    Na YM; Cho JS; Park MH
    Anticancer Res; 2021 Nov; 41(11):5713-5721. PubMed ID: 34732444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative subclinical hypothyroidism in patients with papillary thyroid carcinoma.
    Ahn D; Sohn JH; Kim JH; Shin CM; Jeon JH; Park JY
    Am J Otolaryngol; 2013; 34(4):312-9. PubMed ID: 23357595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy.
    Ito M; Miyauchi A; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nishikawa M; Nakamura H; Amino N
    Thyroid; 2017 Apr; 27(4):484-490. PubMed ID: 28056660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing TSH suppression efficacy in postoperative papillary thyroid carcinoma patients: a retrospective cohort study.
    Zhang Q; Zhong ZZ; Wu T; He YQ
    BMC Surg; 2024 May; 24(1):133. PubMed ID: 38702652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Recovery of Thyroid Function in Low-Risk Papillary Thyroid Cancer After Lobectomy: A 3-Year Follow-Up Study.
    Dou Y; Chen Y; Hu D; Su X
    Front Endocrinol (Lausanne); 2020; 11():619841. PubMed ID: 33633689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of serum thyroid-stimulating hormone level post-lobectomy in low- and intermediate-risk papillary thyroid carcinoma.
    Park JH; Lee YM; Lee YH; Hong SJ; Yoon JH
    J Surg Oncol; 2018 Sep; 118(3):390-396. PubMed ID: 30114333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.
    Lun Y; Wu X; Xia Q; Han Y; Zhang X; Liu Z; Wang F; Duan Z; Xin S; Zhang J
    Otolaryngol Head Neck Surg; 2013 Mar; 148(3):396-402. PubMed ID: 23300224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncological impact of hypothyroidism and levothyroxine supplementation following hemithyroidectomy in patients with papillary thyroid carcinoma.
    Ahn D; Lee GJ; Sohn JH; Jeon JH
    Head Neck; 2020 May; 42(5):1004-1013. PubMed ID: 31930773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Outcomes and Risk Factors for Recurrence After Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
    Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2016 Feb; 26(2):262-70. PubMed ID: 26566765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Features of Early and Late Postoperative Hypothyroidism After Lobectomy.
    Park S; Jeon MJ; Song E; Oh HS; Kim M; Kwon H; Kim TY; Hong SJ; Shong YK; Kim WB; Sung TY; Kim WG
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1317-1324. PubMed ID: 28324106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with postoperative hypothyroidism after lobectomy in papillary thyroid microcarcinoma patients.
    Park HK; Kim DW; Ha TK; Choo HJ; Park YM; Jung SJ; Kim DH; Bae SK
    Endocr Res; 2015; 40(1):49-53. PubMed ID: 25111668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
    Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
    Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study.
    Del Duca SC; Santaguida MG; Brusca N; Gatto I; Cellini M; Gargano L; Verga Falzacappa C; Frattaroli FM; Virili C; Centanni M
    Eur J Endocrinol; 2015 Sep; 173(3):351-7. PubMed ID: 26092761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the presence of remnant thyroid tissue on the serum thyroid hormone balance in thyroidectomized patients.
    Ito M; Miyauchi A; Kang S; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nakamura H; Amino N
    Eur J Endocrinol; 2015 Sep; 173(3):333-40. PubMed ID: 26077156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy.
    Ito M; Miyauchi A; Morita S; Kudo T; Nishihara E; Kihara M; Takamura Y; Ito Y; Kobayashi K; Miya A; Kubota S; Amino N
    Eur J Endocrinol; 2012 Sep; 167(3):373-8. PubMed ID: 22711760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Re-recurrence After First Reoperative Surgery for Locoregional Recurrent/Persistent Papillary Thyroid Carcinoma.
    Lee HS; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    World J Surg; 2015 Aug; 39(8):1943-50. PubMed ID: 25820911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up.
    Kim SY; Kim HJ; Kim SM; Chang H; Lee YS; Chang HS; Park CS
    Front Endocrinol (Lausanne); 2020; 11():520. PubMed ID: 32849303
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for hypothyroidism and thyroid hormone replacement after hemithyroidectomy in papillary thyroid carcinoma.
    Lee SJ; Song CM; Ji YB; Choi YY; Sohn YS; Park JH; Kim DS; Tae K
    Langenbecks Arch Surg; 2021 Jun; 406(4):1223-1231. PubMed ID: 33970335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.